No evidence of platelet dysfunction or an increase in surgical bleeding after administration of inhaled epoprostenol has been found.
Non hai evidencias de disfunción plaquetaria ou de incremento de hemorraxias cirúrxicas despois da administración de epoprostenol inhalado.